UBS Group’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.45M Hold
3,542,164
﹤0.01% 4924
2026
Q1
$3.15M Hold
3,542,164
﹤0.01% 4548
2025
Q4
$4.92M Hold
3,542,164
﹤0.01% 4046
2025
Q3
$7.05M Hold
3,542,164
﹤0.01% 3676
2025
Q2
$6.77M Hold
3,542,164
﹤0.01% 3547
2025
Q1
$4.75M Hold
3,542,164
﹤0.01% 3830
2024
Q4
$5.63M Hold
3,542,164
﹤0.01% 3697
2024
Q3
$5.1M Hold
3,542,164
﹤0.01% 3053
2024
Q2
$6.8M Hold
3,542,164
﹤0.01% 2554
2024
Q1
$15.7M Buy
+3,542,164
New +$11.5M ﹤0.01% 1883

Other funds holding SKIN

UBS Group's SKIN Position: Q2 2026 in Review

UBS Group increased its SkinHealth Systems (SKIN) stake by 249% in Q2 2026, buying an estimated $458K and bringing the position to 839,383 shares worth $582K. The position accounts for ﹤0.01% of the portfolio, ranked #6138.

UBS Group first reported a position in SKIN in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.82M in Q1 2024. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • UBS Group held 839,383 shares of SkinHealth Systems worth $582K as of Q2 2026.
  • UBS Group bought 599,031 SkinHealth Systems shares in Q2 2026, an estimated $458K.
  • SkinHealth Systems made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6138 holding.
  • UBS Group first reported a position in SkinHealth Systems in Q1 2021 and has held it in 22 quarters since.
  • UBS Group's SkinHealth Systems position peaked at $1.82M in Q1 2024.
  • 96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.